Related Experiment Video
Updated: Jul 13, 2025

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
Published on: September 27, 2024
TWEAK Progress in Dermatology: A Review
Pramisha Kharel1, Chen Jia1, Kamal Raj Dhital2
1From the Department of Rheumatology and Immunology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
Abstract:
Tumour necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) is a member of the TNF superfamily (TNFSF). It acts through its receptor fibroblast growth factor-inducible 14 (Fn14). Studies have indicated that TWEAK/Fn14 pathway activation controls multiple cellular responses, including proliferation, angiogenesis and induction of inflammatory cytokines. TWEAK/Fn14 is manifested in many tissues of our body and most importantly in the skin causing inflammation and many autoimmune and neoplastic cutaneous disorders. Evidence suggests that the TWEAK/Fn14 axis, the downstream signalling pathway and its inflammatory molecular expressions are involved in the pathogenesis of many cutaneous disorders such as psoriasis, atopic dermatitis (AD) vitiligo and melanoma. So, this literature review describes a brief introduction of TWEAK and TWEAK/Fn14 pathway and summarises the case-series and open-label studies performed in the field of dermatology and its potential therapeutic benefit.
Insights
Tumour necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) and its receptor fibroblast growth factor-inducible 14 (Fn14) pathway are implicated in skin inflammation and autoimmune diseases. This review explores TWEAK/Fn14
Area of Science:
- Dermatology and immunology
- Molecular biology
- Cellular signaling
Background:
- Tumour necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) is a TNF superfamily member.
- TWEAK signals through its receptor fibroblast growth factor-inducible 14 (Fn14).
- The TWEAK/Fn14 pathway regulates cellular proliferation, angiogenesis, and inflammatory cytokine induction.
Purpose of the Study:
- To provide an overview of the TWEAK/Fn14 pathway.
- To review its role in cutaneous disorders.
- To summarize therapeutic potential in dermatology.
Main Methods:
- Literature review of case-series and open-label studies.
- Focus on dermatological applications.
Main Results:
- TWEAK/Fn14 pathway is present in various tissues, notably the skin.
- This pathway is involved in the pathogenesis of inflammatory and neoplastic skin conditions.
- Includes psoriasis, atopic dermatitis (AD), vitiligo, and melanoma.
Conclusions:
- The TWEAK/Fn14 axis plays a significant role in skin inflammation and disease.
- Further research into TWEAK/Fn14 modulation may offer therapeutic benefits for dermatological conditions.
Related Concept Videos
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Clinical Applications of Epidermal Stem Cells
Renewal of Skin Epidermal Stem Cells
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Reticular Dermis
Reticular Layer
Underlying the papillary layer is the much thicker reticular layer, composed of dense, irregular connective...
Papillary Dermis
The dermis might be considered the "core" of the integumentary system, as distinct from the epidermis and hypodermis. It contains blood and lymph vessels, nerves, and other structures, such as hair follicles and sweat glands. The dermis is made of two layers of connective tissue that comprise an interconnected mesh of elastin and collagenous fibers, produced by fibroblasts.
Papillary Layer
The papillary layer is made of loose, areolar connective tissue, which means the collagen...

